Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin
Daschle Nomination For HHS Secretary Held Up in Senate Finance Committee; Corr Nominated Deputy HHS Secretary
FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products
FDA, Companies Fail To Collect COI Forms, Report Says
Sledge Elected ASCO President
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









